📰 Nasdaq Scph News
Nasdaq Scph News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Nasdaq Scph. Real-time updates on events, politics, business and more.
February 16, 2024
AIGH Capital Management LLC lifted its stake in scPharmaceuticals Inc. (NASDAQ:SCPH – Free Report) by 7.6% during the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 2,207,009 shares of the company’s stock after buying an additional 155,204 shares during the quarter. scPharmaceuticals makes up about 7.4% of AIGH […]
February 7, 2024
ScPharmaceuticals Inc. (NASDAQ:SCPH – Free Report) – Analysts at Leerink Partnrs issued their FY2027 earnings estimates for scPharmaceuticals in a research report issued to clients and investors on Monday, February 5th. Leerink Partnrs analyst R. Ruiz expects that the company will earn $2.55 per share for the year. The consensus estimate for scPharmaceuticals’ current full-year […]
August 30, 2023
Tower Research Capital LLC TRC increased its holdings in scPharmaceuticals Inc. (NASDAQ:SCPH – Free Report) by 17.5% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 16,982 shares of the company’s stock after buying an additional 2,533 shares during the quarter. Tower […]
August 27, 2023
ScPharmaceuticals (NASDAQ:SCPH – Get Free Report) and Pulmatrix (NASDAQ:PULM – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, valuation, earnings, profitability and risk. Analyst Recommendations This is a summary of recent ratings […]
August 25, 2023
ScPharmaceuticals (NASDAQ:SCPH – Get Free Report) and Pulmatrix (NASDAQ:PULM – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, valuation, earnings, institutional ownership, analyst recommendations, risk and profitability. Volatility and Risk scPharmaceuticals has a beta of 0.17, […]
August 13, 2023
Cowen AND Company LLC acquired a new position in scPharmaceuticals Inc. (NASDAQ:SCPH – Free Report) during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 2,807,562 shares of the company’s stock, valued at approximately $25,465,000. scPharmaceuticals accounts for 3.0% of Cowen AND […]
July 19, 2023
Shares of scPharmaceuticals Inc. (NASDAQ:SCPH – Get Free Report) have been assigned an average rating of “Buy” from the six analysts that are currently covering the stock, MarketBeat.com reports. Six equities research analysts have rated the stock with a buy recommendation. The average 12 month price target among brokers that have issued ratings on the […]
June 26, 2023
Shares of scPharmaceuticals Inc. (NASDAQ:SCPH – Get Rating) have been assigned a consensus rating of “Buy” from the six brokerages that are presently covering the firm, MarketBeat.com reports. Six analysts have rated the stock with a buy rating. The average twelve-month target price among brokers that have issued ratings on the stock in the last […]
June 1, 2023
ScPharmaceuticals Inc. (NASDAQ:SCPH – Get Rating) has earned a consensus recommendation of “Buy” from the six brokerages that are covering the company, Marketbeat Ratings reports. Five research analysts have rated the stock with a buy recommendation. The average twelve-month target price among analysts that have updated their coverage on the stock in the last year […]
May 30, 2023
ScPharmaceuticals Inc. (NASDAQ:SCPH – Get Rating) has received an average recommendation of “Buy” from the six analysts that are covering the stock, MarketBeat.com reports. Five research analysts have rated the stock with a buy rating. The average 1-year target price among analysts that have covered the stock in the last year is $19.17. A number […]